Abu DayyehB.K, YangM., FuchsB.C., KarlD.L., YamadaS., SninskyJ.J., O'BrienT.R., DienstagJ.L., TanabeK.K., ChungR.T.HALT-C Trial Group. 2011. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology, 141:141–149.
2.
AraújoA.P., CatarinoR., RibeiroR., PereiraD., PintoD., MedeirosR.2011a. Epidermal growth factor genetic variation associated with advanced cervical cancer in younger women. Am J Clin Oncol[Epub ahead of print]DOI: 10.1097/COC.0b013e31820dbbf5.
3.
AraújoA.P., CostaB.M., Pinto-CorreiaA.L., FragosoM., FerreiraP., Dinis-RibeiroM., CostaS., ReisR.M., MedeirosR.2011b. Association between EGF+61A/G polymorphism and gastric cancer in Caucasians. World J Gastroenterol, 17:488–492.
4.
AraújoA.P., RibeiroR., PereiraD., PintoD., SousaB., CatarinoR., MedeirosR.2009a. Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene. Exp Biol Med (Maywood), 234:241–245.
5.
AraújoA.P., RibeiroR., PintoD., PereiraD., SousaB., MauricioJ., LopesC., MedeirosR.2009b. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease. DNA Cell Biol, 28:265–269.
6.
EggerM., DaveyS.G., SchneiderM., MinderC.1997. Bias in meta-analysis detected by a simple, graphical test. BMJ, 315:629–634.
7.
HandollH.H.2006. Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil, 87:875.
8.
KangH.G., ChoiJ.E., LeeW.K., KamS., ChaS.I., KimC.H., JungT.H., ParkJ.Y.2007a. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology, 12:902–905.
LiT.F., RenK.W., LiuP.F.2011. Meta-analysis of epidermal growth factor polymorphisms and cancer risk: involving 9,779 cases and 15,932 controls. DNA Cell Biol[Epub ahead of print]DOI: 10.1089/dna.2011.1394.
11.
MiY.Y., ZhuL.J., YouX.M., WuS.2012. Clarification of Data for a Recent Meta-Analysis-Epidermal Growth Factor Polymorphisms and Cancer Risk: Involving 9,779 Cases and 15,932 Controls. DNA Cell Biol[Epob ahead of print]DOI: 10.1089/dna.2011.1569.
12.
ShahbaziM., PravicaV., NasreenN., FakhouryH., FryerA.A., StrangeR.C., HutchinsonP.E., OsborneJ.E., LearJ.T., SmithA.G., HutchinsonI.V.2002. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet, 359:397–401.
13.
VauleonE., AugerN., Benouaich-AmielA., Laigle-DonadeyF., KaloshiG., LejeuneJ., DelattreJ.Y., ThilletJ., SansonM.2007. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet, 172:33–37.
